Venus Remedies Ltd.
VENUSREM (NSE)

211.20

267.14
Proj. ROE (%)
-
Proj. P/E (x)
-
Proj EV / EBITDA (x)
-
Proj. P/BV (x)
-
Proj. Revenue ( Cr.)
-

Stock View

-
Share on
The average score for Venus Remedies Ltd. stands at 7 against 8, three months back.

Venus Remedies Limited is an India-based research pharmaceutical company. The Company operates in Pharmaceutical Formulation segment. The Company is engaged in manufacturing and trading of medicines. It manufactures products catering to critical care segments, such as anticancer, anti-infective, neurology, skin and wound care, and pain management. The Company’s brands include Supime, Clindol, Pisa, Ronem, Megaparin and Coguperin. It has its manufacturing facilities in Panchkula and Baddi (in India) and Werne (in Germany) and a research and development center in Venus Medicine Research Center (in India). The Company has its presence in approximately 75 companies. The Company’s wholly owned subsidiary is Venus Pharma GmbH, which deals in licensing, packaging, product testing, warehousing and logistics.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
246.39
100 DMA ()
274.33
200 DMA ()
358.58
52 Weeks Range
177.60
639.00
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity